Remove 2019 Remove Clinical Practice Remove Individual Remove Patients
article thumbnail

Position Statement on Measurement Based Care

Integrated Care News by CFHA

MBC supports optimal clinical practice, demonstrates the value of integrated care teams, and improves outcomes. MBC is a clinical process that includes repeated measurement to monitor treatment progress and to inform collaborative treatment planning over the course of care. (1) 3, 4) Why is MBC important? 3, 5, 6) b. 1, 8, 9) d.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Criterion 2 : Non-Device CDS software functions display, analyze or print medical information about a patient or other medical information.

Clinic 52
article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. We address: Why is caring for patients with this overlap so hard? Sach Kale set up an outpatient clinic focused on substance use disorder for patients with cancer. Why am I having difficulty with this patient?

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Early data on efficacy in patients with anxiety and demoralization are promising. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics.

article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

But, should we as clinicians care about the social lives of our patients? Are there meaningful ways of assessing loneliness and social isolation in clinical settings and connecting patients with interventions? Has kept me interested, the patient experience and the older adults in the community, their experience.

IT 100
article thumbnail

Do statins reduce mortality in older people? Findings from a longitudinal study using primary care records

BMJ

This is because clinical trials are expensive to carry out and therefore tend to be of relatively short duration, with statins trials having on average two to five years of treatment exposure. 9 The availability of electronic health records makes it easier to follow up on patients’ health information for an extended period.